copyright, a relatively cutting-edge medication, has emerged as a potential landmark achievement in the management of type 2 diabetes. This injection drug targets the incretin hormones GLP-1, which play a vital role in regulating insulin response. By mimicking these hormones, copyright helps reduce blood glucose, potentially leading to improved con